Por favor, use este identificador para citar o enlazar a este item: http://hdl.handle.net/10261/86863
COMPARTIR / EXPORTAR:
logo share SHARE logo core CORE BASE
Visualizar otros formatos: MARC | Dublin Core | RDF | ORE | MODS | METS | DIDL | DATACITE

Invitar a revisión por pares abierta
Título

The extradomain A of fibronectin (EDA) combined with poly(I: C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model

AutorSan Román, Beatriz CSIC ORCID ; Andrés, Ximena de CSIC; Muñoz, Pilar M. CSIC ORCID; Obregón, Patricia CSIC; Asensio, Aaron C.; Garrido, Victoria CSIC ORCID ; Andrés, Damián F. de CSIC ORCID ; Amorena Zabalza, Beatriz CSIC ORCID ; Grilló, María Jesús CSIC ORCID
Fecha de publicación28-mar-2012
EditorElsevier
CitaciónVaccine 30(15): 2564-2569 (2012)
ResumenThe development of effective vaccines against HIV-1 infection constitutes one of the major challenges in viral immunology. One of the protein candidates in vaccination against this virus is p24, since it is a conserved HIV antigen that has cytotoxic and helper T cell epitopes as well as B cell epitopes that may jointly confer enhanced protection against infection when used in immunization-challenge approaches. In this context, the adjuvant effect of EDA (used as EDAp24 fusion protein) and poly(I:C), as agonists of TLR4 and TLR3, respectively, was assessed in p24 immunizations using a recombinant Listeria monocytogenes HIV-1 Gag proteins (Lm-Gag, where p24 is the major antigen) for challenge in mice. Immunization with EDAp24 fusion protein together with poly(I:C) adjuvant induced a specific p24 IFN-γ production (Th1 profile) as well as protection against a Lm-Gag challenge, suggesting an additive or synergistic effect between both adjuvants. The combination of EDA (as a fusion protein with the antigen, which may favor antigen targeting to dendritic cells through TLR4) and poly(I:C) could thus be a good adjuvant candidate to enhance the immune response against HIV-1 proteins and its use may open new ways in vaccine investigations on this virus. © 2012 Elsevier Ltd.
DescripciónSan Román, Beatriz et al.
Versión del editorhttp://dx.doi.org/10.1016/j.vaccine.2012.01.081
URIhttp://hdl.handle.net/10261/86863
DOI10.1016/j.vaccine.2012.01.081
Identificadoresdoi: 10.1016/j.vaccine.2012.01.081
issn: 0264-410X
Aparece en las colecciones: (IDAB) Artículos




Ficheros en este ítem:
Fichero Descripción Tamaño Formato
extradomain_a_fibronectin_San_Roman.pdf284,95 kBAdobe PDFVista previa
Visualizar/Abrir
Mostrar el registro completo

CORE Recommender

SCOPUSTM   
Citations

7
checked on 25-abr-2024

WEB OF SCIENCETM
Citations

8
checked on 28-feb-2024

Page view(s)

419
checked on 29-abr-2024

Download(s)

445
checked on 29-abr-2024

Google ScholarTM

Check

Altmetric

Altmetric


NOTA: Los ítems de Digital.CSIC están protegidos por copyright, con todos los derechos reservados, a menos que se indique lo contrario.